Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Interchangeability Won’t Solve US Biosimilar Market’s Woes, FDA’s Gottlieb Says

Jul 19 2018

• By Sue Sutter

Gottlieb at Bookings July 2018

Related Content

US FDA Biosimilar Guidance Update Will Relax Interchangeability Standards

Apr 21 2018

Biosimilars Need Better Reimbursement, Not 'Kabuki' Coverage, Gottlieb Tells Insurers

Mar 08 2018

Biosimilars For US Market May Be Able To Rely On EU-Licensed Reference Products

Jul 17 2018

Biosimilar Switching Studies, Human Factors Analyses Are Flashpoints For Industry

Jun 01 2017

Related Companies

Viatris Inc.

Amgen, Inc.

Additional Topics

United States Biologics Biosimilars Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.